Barclays Keeps Their Hold Rating on Galapagos (0JXZ)
In a report released today, Emily Field from Barclays maintained a Hold rating on Galapagos (0JXZ – Research Report), with a price target of ...
Healio3 天
Ivarmacitinib curbs rheumatoid arthritis symptoms, improves function through 52 weeks
A once-daily dose of ivarmacitinib reduced disease activity and improved function among patients with rheumatoid arthritis ...
manilatimes6 天
Technoderma Medicines Completes Positive Ph2a Proof- of Concept Trial with Topical TDM ...
Technoderma Medicines, Inc. ('the Company'), a clinical stage biopharmaceutical company, is pleased to report the Company has completed its Phase 2a clinical trial (NCT06363461) of topical TDM-180935 ...